TASK FORCES:


The Gold Standard is a workplace- based program that focuses on lowering the risk of cancer.
Visit Website



The Life Sciences Consortium (LSC) brings together oncology companies to accelerate discovery and development of new therapies for all cancer patients. Visit Website

Leadership Team

Board of Directors of the CEO Roundtable on Cancer

Robert A. Bradway

Chairman, CEO Roundtable on Cancer
Chairman and Chief Executive Officer, Amgen

Christopher A. Viehbacher

Immediate Past Chairman, CEO Roundtable on Cancer
Managing Partner, Gurnet Point Capital

William C. Weldon

Past Chairman, CEO Roundtable on Cancer
Former Chairman of the Board and Chief Executive Officer, Johnson & Johnson

Robert A. Ingram

Past Chairman and Co-Founder, CEO Roundtable on Cancer
General Partner, Hatteras Venture Partners

Martin J. Murphy, DMedSc, PhD, FASCO

Chief Executive Officer, CEO Roundtable on Cancer
Chairman of the Board and Chief Executive Officer, AlphaMed Consulting

Mimi Hancock, PhD

Board Member, CEO Roundtable on Cancer
Partner, Spencer Stuart

Life Sciences Consortium Task Force Leadership

Gregory A. Curt, M.D.

Co-Chairman, Life Sciences Consortium Task Force
Executive Director for External Relations in US Medical Affairs, AstraZeneca

Mace Rothenberg, M.D.

Co-Chairman, Life Sciences Consortium Task Force
Chief Medical Officer & Senior Vice President, Clinical Development & Medical Affairs for the Oncology Business Unit at Pfizer’s Global Research and Development

CEO Cancer Gold Standard™ Task Force Leadership

Judy O'Hagan

Co-Chair, CEO Cancer Gold Standard™
Vice President, US, Human Resources, Sanofi

Fikry W. Isaac, MD, MPH, FACOEM

Co-Chair, CEO Cancer Gold Standard™
Vice President of Global Health Services, Johnson & Johnson

CEO Roundtable on Cancer Staff

John N. Dornan

Executive Director, CEO Roundtable on Cancer